Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2011 10:00 ET | Source: Infinity Pharmaceuticals, Inc.

Photo Release -- Biopharmaceutical Company Seeks New Sources of Corn Lily

SALT LAKE CITY and BOISE, Idaho, June 22, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc., a Massachusetts-based biopharmaceutical company, is seeking new sources of a plant commonly known as...
June 22, 2011 08:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Expands Clinical Development Program for IPI-926, an Oral Smoothened Antagonist Targeting the Hedgehog Pathway

CAMBRIDGE, Mass., June 22, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced that it is expanding its clinical development program for IPI-926, a novel, oral small...
May 10, 2011 16:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Reports First Quarter 2011 Financial Results

— Reaffirms 2011 Financial Guidance and Provides Additional Details — — Anticipates Completion of Patient Enrollment in Phase 2 Trial of IPI-926 in Pancreatic Cancer...
April 03, 2011 13:36 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Reports New Preclinical Data for IPI-926 at AACR Supporting Development in Chondrosarcoma

CAMBRIDGE, Mass., April 3, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced encouraging results for its novel Smoothened antagonist, IPI-926, in a preclinical...
March 15, 2011 16:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Provides Company Update and Reports Fourth Quarter and Full-Year 2010 Financial Results

IPI-926 Advancing in Two Phase 2 Trials, Underscoring Pipeline Momentum Cash Runway Into 2014 Enables Advancement of Product Candidates to Key Inflection Points Company Changes Accounting...